GlassScriptPhysician profile
Jared Deneil Cordon
NPI 1649409251
$1,495.01
in general payments reported to CMS, 2019-2025
26 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.91 · 2020: $56.39 · 2021: $465 · 2022: $130 · 2023: $321 · 2024: $272 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $521.93 | 2021-2024 | Inhance, Healix Knotless Peek, Dynatape |
| Djo, LLC | $112.11 | 2021-2025 | Cmf |
| Pacira Therapeutics, INC. | $100.16 | 2020-2021 | |
| Medical Device Business Services, INC. | $99.02 | 2022-2023 | Inhance |
| Stryker Corporation | $82.59 | 2024-2025 | Tritanium, Infinity Adaptis, Triathlon |
| Boston Scientific Corporation | $49.97 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Convatec INC. | $48.33 | 2019-2022 | |
| Abbvie INC. | $43.53 | 2022-2025 | Dalvance |
| Integra Lifesciences Corporation | $41.60 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Vertex Pharmaceuticals Incorporated | $39.75 | 2025 | |
| Radius Health, INC. | $39.11 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $35.79 | 2024 | Zilretta, Iovera |
| Fidia Pharma USA INC. | $33.17 | 2022-2025 | Triluron, Hymovis |
| Abbott Laboratories | $29.91 | 2025 | Eterna |
| Averitas Pharma INC. | $24.33 | 2023 | Qutenza |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $24.31 | 2019-2021 | |
| Vericel Corporation | $23.05 | 2024 | Maci |
| Skeletal Dynamics INC | $20.54 | 2024-2025 | Align, Implate, Geminus |
| Medtronic, INC. | $19.35 | 2024 | Intellis Adaptivestim |
| Organogenesis INC. | $16.82 | 2023 | Puraply |
| Kerecis Limited | $16.28 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Endo USA, INC. | $15.67 | 2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $15.61 | 2021 | |
| Acell, INC. | $15.42 | 2020 | |
| Linvatec Corporation | $15.01 | 2023 | Linvatec Extremities, Biobrace 23mm |
| Heron Therapeutics, INC. | $11.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Cordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.